WallStSmart
IONS

Ionis Pharmaceuticals Inc

NASDAQ: IONS · HEALTHCARE · BIOTECHNOLOGY

$74.76
-0.09% today

Updated 2026-04-30

Market cap
$11.85B
P/E ratio
P/S ratio
12.56x
EPS (TTM)
$-2.38
Dividend yield
52W range
$30 – $87
Volume
2.2M

Ionis Pharmaceuticals Inc (IONS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$14.86M$58.34M$107.19M$121.60M$108.47M$99.09M$102.05M$147.28M$214.16M$283.70M$346.62M$514.18M$599.67M$1.12B$729.00M$810.46M$587.37M$787.65M$705.14M$944.00M
Revenue growth (YoY)+292.7%+83.7%+13.4%-10.8%-8.7%+3.0%+44.3%+45.4%+32.5%+22.2%+48.3%+16.6%+87.3%-35.1%+11.2%-27.5%+34.1%-10.5%+33.9%
Cost of revenue$5.78M$10.97M$38.18M$47.80M$35.42M$14.52M$158.46M$184.03M$241.75M$322.29M$344.32M$374.64M$1.82M$4.00M$12.00M$10.84M$14.12M$9.13M$11.21M$16.00M
Gross profit$24.53M$69.62M$107.19M$121.60M$108.47M$99.09M$-56.41M$-36.75M$-27.59M$-38.59M$2.30M$514.18M$597.85M$1.12B$717.00M$799.61M$573.25M$778.51M$693.92M$928.00M
Gross margin165.1%119.3%100.0%100.0%100.0%100.0%-55.3%-25.0%-12.9%-13.6%0.7%100.0%99.7%99.6%98.4%98.7%97.6%98.8%98.4%98.3%
R&D$80.57M$92.64M$106.44M$134.62M$145.16M$157.40M$158.46M$184.03M$241.75M$322.29M$344.32M$374.64M$414.60M$466.00M$535.00M$643.00M$833.00M$899.63M$901.53M$916.00M
SG&A$12.62M$15.93M$13.81M$14.52M$11.67M$12.79M$12.52M$14.92M$20.14M$37.17M$48.62M$108.49M$244.62M$287.00M$354.00M$170.90M$150.30M$232.60M$267.50M$393.90M
Operating income$-65.22M$-32.92M$-13.06M$-27.54M$-48.36M$-71.10M$-68.92M$-51.67M$-47.73M$-75.76M$-46.32M$31.05M$-61.37M$366.00M$-172.00M$-30.19M$-410.19M$-353.73M$-475.08M$-382.00M
Operating margin-438.9%-56.4%-12.2%-22.6%-44.6%-71.8%-67.5%-35.1%-22.3%-26.7%-13.4%6.0%-10.2%32.6%-23.6%-3.7%-69.8%-44.9%-67.4%-40.5%
EBITDA$-58.54M$-26.15M$4.11M$-16.21M$-38.75M$-56.27M$-42.68M$-41.88M$-22.78M$-40.94M$-37.28M$36.34M$-18.84M$381.99M$-154.84M$-5.19M$-227.76M$-235.87M$-353.72M$-286.75M
EBITDA margin-394.0%-44.8%3.8%-13.3%-35.7%-56.8%-41.8%-28.4%-10.6%-14.4%-10.8%7.1%-3.1%34.0%-21.2%-0.6%-38.8%-29.9%-50.2%-30.4%
EBIT$-65.75M$-32.92M$-2.71M$-27.54M$-47.93M$-68.06M$-53.44M$-51.67M$-32.18M$-51.17M$-46.32M$27.99M$-31.37M$366.00M$-172.00M$-24.75M$-249.86M$-258.37M$-375.71M$-307.00M
Interest expense$9.03M$7.57M$5.60M$12.67M$13.23M$16.73M$21.15M$19.36M$22.21M$36.73M$38.80M$44.75M$44.79M$49.00M$44.99M$9.35M$8.12M$81.46M$90.45M$73.00M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-45.90M$-10.99M$-18.17M$155.07M$-61.25M$-84.80M$-65.48M$-60.64M$-38.98M$-88.28M$-86.56M$346000.00$273.74M$294.00M$-487.00M$-28.60M$-269.72M$-366.29M$-453.90M$-381.00M
Net income growth (YoY)+76.0%-65.3%+953.3%-139.5%-38.4%+22.8%+7.4%+35.7%-126.4%+2.0%+100.4%+79015.9%+7.4%-265.6%+94.1%-843.2%-35.8%-23.9%+16.1%
Profit margin-308.9%-18.8%-17.0%127.5%-56.5%-85.6%-64.2%-41.2%-18.2%-31.1%-25.0%0.1%45.6%26.2%-66.8%-3.5%-45.9%-46.5%-64.4%-40.4%